Jack Hirsh

Jack Hirsh

McMaster University

H-index: 181

North America-Canada

About Jack Hirsh

Jack Hirsh, With an exceptional h-index of 181 and a recent h-index of 53 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Thrombosis andnhemostasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Human papilloma virus and atherosclerotic cardiovascular disease

FRAIL-AF trial: more bleeding with DOACs compared with VKAs in patients with frailty?

C-CASE 2023: Promoting Excellence in Surgical Education01. Near-peer tutoring: an effective adjunct for virtual anatomy learning02. Surgical Exploration and Discovery …

Unresolved issues in the use of direct acting oral anticoagulants

Clinical Studies

Clinical studies with anticoagulants that have changed clinical practice

Inflammation as a mechanism and therapeutic target in peripheral artery disease

Can a single measurement of apixaban levels identify patients at risk of overexposure? A prospective cohort study

Jack Hirsh Information

University

Position

Emeritus professor of medicine Ontario canada

Citations(all)

240121

Citations(since 2020)

46694

Cited By

204081

hIndex(all)

181

hIndex(since 2020)

53

i10Index(all)

728

i10Index(since 2020)

238

Email

University Profile Page

McMaster University

Google Scholar

View Google Scholar Profile

Jack Hirsh Skills & Research Interests

Thrombosis andnhemostasis

Top articles of Jack Hirsh

Title

Journal

Author(s)

Publication Date

Human papilloma virus and atherosclerotic cardiovascular disease

Noel C Chan

James S Lawson

Jack Hirsh

2024/2/7

FRAIL-AF trial: more bleeding with DOACs compared with VKAs in patients with frailty?

The Canadian Journal of Cardiology

Alejandro Godoy

Noel C Chan

Vinai Bhagirath

John W Eikelboom

Jack Hirsh

2024/1/2

C-CASE 2023: Promoting Excellence in Surgical Education01. Near-peer tutoring: an effective adjunct for virtual anatomy learning02. Surgical Exploration and Discovery …

Jeffrey Sioufi

Sarah Moussa

Sonaina Chopra

Mohamed S Bondok

Nancy Posel

...

2023/12/8

Unresolved issues in the use of direct acting oral anticoagulants

Noel Chan

Jack Hirsh

2023/12/2

Clinical Studies

Journal of Immunotherapy

Zhao Jin

Minghe Zhao

2023/9

Clinical studies with anticoagulants that have changed clinical practice

Jack Hirsh

Tim AC de Vries

John W Eikelboom

Vinai Bhagirath

Noel C Chan

2023/4

Inflammation as a mechanism and therapeutic target in peripheral artery disease

Noel C Chan

Ke Xu

Tim AC de Vries

John W Eikelboom

Jack Hirsh

2022/5/1

Can a single measurement of apixaban levels identify patients at risk of overexposure? A prospective cohort study

TH Open

Tim AC de Vries

Jack Hirsh

Vinai C Bhagirath

Jeffrey S Ginsberg

Ron Pisters

...

2022/1

Letter by de Vries et al regarding article “off-label under-and overdosing of direct oral anticoagulants in patients with atrial fibrillation: a meta-analysis”

Circulation: Cardiovascular Quality and Outcomes

Tim AC de Vries

Jack Hirsh

Noel C Chan

2022/5

The" Forgotten Ones": The Natural and Unnatural History of Univentricular Physiology Without Fontan Palliation.

The Canadian Journal of Cardiology

Danielle Massarella

Erwin Oechslin

2021/11/11

Plasma rivaroxaban level to identify patients at risk of drug overexposure: is a single measurement of drug level reliable?

TH Open

Krishnan Shyamkumar

Jack Hirsh

Vinai C Bhagirath

Jeffrey S Ginsberg

John W Eikelboom

...

2021/1

Peripheral oxygen saturation in older persons wearing nonmedical face masks in community settings

JAMA

Noel C Chan

Karen Li

Jack Hirsh

2020/12/8

Nadroparin plus compression stockings versus nadroparin alone for prevention of venous thromboembolism in cerebellopontine angle tumour excisions: a cohort study

Thrombosis and Haemostasis

Raoul J Koopmans

Suzanne C Cannegieter

Radboud W Koot

Carmen LA Vleggeert-Lankamp

2020/3

Apixaban for stroke prevention in atrial fibrillation: why are event rates higher in clinical practice than in randomized trials?—a systematic review

Tim AC de Vries

Jack Hirsh

Ke Xu

Imaad Mallick

Vinai C Bhagirath

...

2020/9

Temporal changes in fibrinolysis following injury

Hunter B Moore

Ernest E Moore

2020/3

Comparative analysis of a French prospective series of 144 patients with heparin-induced thrombocytopenia (FRIGTIH) and the literature

Thrombosis and Haemostasis

Yves Gruel

Caroline Vayne

Jérôme Rollin

Pierre Weber

Dorothée Faille

...

2020/7

Postoperative venous thromboembolism prophylaxis: changes in the daily clinical practice, modified guidelines

Charles Marc Samama

2020/2

Mortality benefit in the COMPASS trial: is it related to superior statistical power or better efficacy and safety?

Krishnan Shyamkumar

Jack Hirsh

Vinai C Bhagirath

Smita Sinha

Ke Xu

...

2020/5

Comparison of continuation of low-molecular-weight heparin versus switching to unfractionated heparin in the peripartum

American Journal of Perinatology

Christopher A Enakpene

Kristina N Pontarelli

Micaela Della Torre

2020/2

The impact of clinical research on clinical practice

Jack Hirsh

2020/4/14

See List of Professors in Jack Hirsh University(McMaster University)